| 臺大學術典藏 |
2021-01-05T00:56:38Z |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Chou W.-C.; Kuo Y.-Y.; Chang Y.-C.; Chen Y.-C.; Hsu S.-C.; Huang S.-Y.; SHANG-JU WU; Tsay W.; Yao M.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; Tang J.-L.; Tien H.-F.; Huang C.-F.; Tseng M.-H.; Liu C.-W.; Kuo K.-T.; Lee F.-Y.; Liu M.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:37Z |
DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications
|
Kuo Y.-Y.; Hou H.-A.; Ko B.-S.; Huang S.-Y.; Yao M.; Tang J.-L.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Liu C.-Y.; Chou W.-C.; Lee M.C.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:37Z |
Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia
|
Chen H.-Y.; Lin C.-W.; Lai Y.-J.; Jhuang J.-Y.; Liu C.-Y.; Lee M.-C.; Cheng C.-L.; Hou H.-A.; Tien H.-F.; Liu F.-T.; Chou W.-C.; Chen C.-Y.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; SHANG-JU WU; Tsay W. |
| 臺大學術典藏 |
2021-01-05T00:56:35Z |
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
|
Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Lai Y.-J.; Hou H.-A.; Lin C.-C.; Chou W.-C.; Liu C.-Y.; Chen C.-Y.; Tang J.-L.; Tsay W.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; SHANG-JU WU; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:35Z |
SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution
|
Tseng M.-H.; Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; SHANG-JU WU; Liu C.-Y.; Chen C.-Y.; Tsay W.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Hsu S.-C.; Ko B.-S.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:35Z |
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients
|
Yang Y.-T.; Chen C.-Y.; Ko B.-S.; Huang S.-Y.; Kuo Y.-Y.; Li C.-C.; Hou H.-A.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Hsu S.-C.; Lin C.-T.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:34Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Lai Y.-J.; Chen C.-Y.; Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Tien H.-F.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; SHANG-JU WU; Tsay W.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:33Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
Lee M.-C.; Lai Y.-J.; Jhuang J.-Y.; Tang J.-L.; Hou H.-A.; Chen Y.-K.; Tien H.-F.; Chen Y.-C.; Tsay W.; SHANG-JU WU; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:33Z |
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
|
Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Liu C.-Y.; Chen C.-Y.; Lin C.-C.; Lai Y.-J.; Hou H.-A.; Kuo Y.-Y.; Tang J.-L.; Chou W.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:32Z |
TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution
|
Tseng M.-H.; Lin L.-I.; Liu C.-Y.; Kuo Y.-Y.; Chou W.-C.; Hou H.-A.; SHANG-JU WU; Lin C.-T.; Chen C.-Y.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:31Z |
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
|
Chen C.-Y.; Liu C.-Y.; Lin C.-C.; Hou H.-A.; Lin Y.-C.; Kuo Y.-Y.; Chou W.-C.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:31Z |
Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)
|
Chiang Y.-C.; Tseng M.-H.; Chou W.-C.; Lin C.-C.; Lin T.-Y.; Yao C.-Y.; Hou H.-A.; Li C.-C.; Hsu S.-C.; Chen C.-Y.; Ko B.-S.; Lin C.-T.; Liao X.-W.; SHANG-JU WU; Liu M.-C.; Liu C.-W.; Kuo Y.-Y.; Huang S.-Y.; Yao M.; Tang J.-L.; Tsay W.; Liu C.-Y.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:28Z |
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
|
Ko B.-S.; Huang S.-Y.; Li C.-C.; Tsai C.-H.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Liu C.-Y.; Tseng M.-H.; Lin T.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Hsu S.-C.; Lin C.-T.; SHANG-JU WU; Chen C.-Y.; Tsay W.; Chuang E.Y.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-04T12:12:46Z |
Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia
|
Tang J.-L.; Chen B.-B.; Liu C.-Y.; Shih T.T.F.; Hou H.-A.; Yao M.; Huang S.-Y.; Chou W.-C.; Hsu C.-Y.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:43Z |
Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia
|
Hou H.-A.; Kuo Y.-Y.; Liu C.-Y.; Lee M.C.; Tang J.-L.; Chen C.-Y.; Chou W.-C.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Yao M.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:35Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Chou W.-C.; Lin C.-C.; Hou H.-A.; HWEI-FANG TIEN; Chen Y.-C.; Tsay W.; Wu S.-J.; Kuo Y.-Y.; Liu C.-Y.; Chen C.-Y.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S. |
| 臺大學術典藏 |
2021-01-04T12:12:33Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
HWEI-FANG TIEN; Tsay W.; Chen Y.-C.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Chen Y.-K.; Hou H.-A.; Tang J.-L.; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-04T12:12:30Z |
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
|
Kuo Y.-Y.; Hou H.-A.; Liu C.-Y.; Huang S.Y.; Li C.-C.; Yao M.; Liu C.-W.; Tang J.-L.; Chiang Y.-C.; Liu M.-C.; Tseng M.-H.; Lin L.-I.; Lin C.-C.; Tsai C.-H.; Chou W.-C.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:28Z |
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
|
Tang J.-L.; Liu C.-Y.; Hou H.-A.; Tsai C.-H.; HWEI-FANG TIEN; Wu S.-J.; Lin C.-T.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Kuo Y.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Tsay W.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:24Z |
Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia
|
Chiang Y.-C.; Tseng M.-H.; Kuo Y.-Y.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Tsai C.-H.; Lin T.-Y.; Hou H.-A.; Lu J.-W.; Peng Y.-L.; Tang J.-L.; Gong Z.; Lin L.-I.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2020-12-30T02:44:21Z |
Changing Epidemiology of Nosocomial Bloodstream Infections in 11 Teaching Hospitals in Taiwan Between 1993 and 2006
|
Liu C.-Y.;Liao C.-H.;Chen Y.-C.;Shan-Chwen Chang; Liu C.-Y.; Liao C.-H.; Chen Y.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2020-12-30T02:43:22Z |
High prevalence of antibiotic resistance of common pathogenic bacteria in Taiwan
|
Liu C.-Y.; SHAN-CHWEN CHANG; Hsieh W.-C.; Shan-Chwen Chang;Hsieh W.-C.;Liu C.-Y. |
| 臺大學術典藏 |
2020-12-29T03:33:13Z |
Emergence of tigecycline-resistant Klebsiella pneumoniae after tigecycline therapy for complicated urinary tract infection caused by carbapenem-resistant Escherichia coli
|
Tsai H.-Y.;Liao C.-H.;Aristine Cheng;Liu C.-Y.;Huang Y.-T.;Sheng W.-H.;Hsueh P.-R.; Tsai H.-Y.; Liao C.-H.; ARISTINE CHENG; Liu C.-Y.; Huang Y.-T.; Sheng W.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2020-12-18T08:40:05Z |
Current status of antimicrobial resistance in Taiwan
|
Luh K.-T.; Liu C.-Y.; PO-REN HSUEH; Po-Ren Hsueh;Liu C.-Y.;Luh K.-T. |
| 臺大學術典藏 |
2020-12-18T08:40:01Z |
Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and β-lactams: SMART program 2001 data
|
Luh K.-T.; Liu C.-Y.; Leu H.-S.; Lee C.-M.; Po-Ren Hsueh;Teng L.-J.;Wu T.-L.;Yang D.;Huang W.-K.;Shyr J.-M.;Chuang Y.-C.;Wan J.-H.;Yan J.-J.;Lu J.-J.;Wu J.-J.;Ko W.-C.;Chang F.-Y.;Yang Y.-C.;Lau Y.-J.;Liu Y.-C.;Lee C.-M.;Leu H.-S.;Liu C.-Y.;Luh K.-T.; PO-REN HSUEH; Teng L.-J.; Wu T.-L.; Yang D.; Huang W.-K.; Shyr J.-M.; Chuang Y.-C.; Wan J.-H.; Yan J.-J.; Lu J.-J.; Wu J.-J.; Ko W.-C.; Chang F.-Y.; Yang Y.-C.; Lau Y.-J.; Liu Y.-C. |
| 臺大學術典藏 |
2020-12-18T08:40:00Z |
Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART program 2001 data
|
Leu H.-S.; Liu Y.-C.; Yang Y.-C.; Lau Y.-J.; Ko W.-C.; Chang F.-Y.; Wu J.-J.; Lu J.-J.; Yan J.-J.; Chuang Y.-C.; Shyr J.-M.; Yang D.; Wan J.-H.; Wu T.-L.; Huang W.-K.; Lee C.-M.; Teng L.-J.; PO-REN HSUEH; Po-Ren Hsueh;Teng L.-J.;Lee C.-M.;Huang W.-K.;Wu T.-L.;Wan J.-H.;Yang D.;Shyr J.-M.;Chuang Y.-C.;Yan J.-J.;Lu J.-J.;Wu J.-J.;Ko W.-C.;Chang F.-Y.;Yang Y.-C.;Lau Y.-J.;Liu Y.-C.;Leu H.-S.;Liu C.-Y.;Luh K.-T.; Liu C.-Y.; Luh K.-T. |
| 臺大學術典藏 |
2020-12-18T08:39:44Z |
Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: Surveillance of Multicenter Antimicrobial Resistance in Taiwan program data from 2003
|
Liu Y.-C.; Yang Y.-C.; Ko W.-C.; Wu J.-J.; Yan J.-J.; Yu K.-W.; Shyr J.-M.; Huang W.-K.; Wan J.-H.; Chuang Y.-C.; Po-Ren Hsueh;Lau Y.-J.;Chuang Y.-C.;Wan J.-H.;Huang W.-K.;Shyr J.-M.;Yan J.-J.;Yu K.-W.;Wu J.-J.;Ko W.-C.;Yang Y.-C.;Liu Y.-C.;Teng L.-J.;Liu C.-Y.;Luh K.-T.; PO-REN HSUEH; Lau Y.-J.; Teng L.-J.; Liu C.-Y.; Luh K.-T. |
| 臺大學術典藏 |
2020-12-18T08:39:36Z |
In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan
|
Cheng N.-C.;Po-Ren Hsueh;Liu Y.-C.;Shyr J.-M.;Huang W.-K.;Teng L.-J.;Liu C.-Y.; Cheng N.-C.; PO-REN HSUEH; Liu Y.-C.; Shyr J.-M.; Huang W.-K.; Teng L.-J.; Liu C.-Y. |
| 臺大學術典藏 |
2020-12-18T08:39:30Z |
Mycobacterium tuberculosis in Taiwan
|
Po-Ren Hsueh;Liu Y.-C.;So J.;Liu C.-Y.;Yang P.-C.;Luh K.-T.; PO-REN HSUEH; Liu Y.-C.; So J.; Liu C.-Y.; Yang P.-C.; Luh K.-T. |
| 臺大學術典藏 |
2020-12-18T08:39:27Z |
Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan
|
Lau Y.-J.;Po-Ren Hsueh;Liu Y.-C.;Shyr J.-M.;Huang W.-K.;Teng L.-J.;Liu C.-Y.;Luh K.-T.; Lau Y.-J.; PO-REN HSUEH; Liu Y.-C.; Shyr J.-M.; Huang W.-K.; Teng L.-J.; Liu C.-Y.; Luh K.-T. |
| 臺大學術典藏 |
2020-12-18T08:39:20Z |
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data
|
Luh K.-T.; Liu C.-Y.; Teng L.-J.; Huang W.-K.; Liu Y.-C.; Wu J.-J.; Ko W.-C.; Shyr J.-M.; Lin C.-F.; Wang J.-H.; Hung M.-N.; PO-REN HSUEH; Chang H.-T.; Lee W.-S.; Chou M.-Y.; Chen I.-S. |
| 臺大學術典藏 |
2020-12-18T08:39:08Z |
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan
|
PO-REN HSUEH; Liao C.-H.; Huang Y.-T.; Liu C.-Y. |
| 臺大學術典藏 |
2020-12-18T08:39:00Z |
Nationwide surveillance of antimicrobial resistance among Enterobacteriaceae in intensive care units in Taiwan
|
Wang J.-H.; Chen I.-S.; Chang H.-T.; Chou M.-Y.; PO-REN HSUEH; Lee W.-S.; Jean S.-S.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; Teng L.-J.; Liu C.-Y. |
| 臺大學術典藏 |
2020-12-18T08:38:59Z |
Nationwide surveillance of antimicrobial resistance among non-fermentative Gram-negative bacteria in Intensive Care Units in Taiwan: SMART programme data 2005
|
Liu C.-Y.; Teng L.-J.; Huang W.-K.; Liu Y.-C.; Wu J.-J.; Ko W.-C.; Shyr J.-M.; Lin C.-F.; Wang J.-H.; Chen I.-S.; Chou M.-Y.; Jean S.-S.; PO-REN HSUEH; Lee W.-S.; Chang H.-T. |
| 臺大學術典藏 |
2020-12-18T08:38:56Z |
Rapidly fatal bacteremia caused by Shigella sonnei without preceding gastrointestinal symptoms in an adult patient with lung cancer
|
Liu C.-Y.; Huang Y.-T.; Liao C.-H.; Chang S.-C.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-12-18T08:38:55Z |
Nationwide surveillance of antimicrobial resistance among haemophilus influenzae and streptococcus pneumoniae in intensive care units in Taiwan
|
Jean S.-S.; PO-REN HSUEH; Lee W.-S.; Chang H.-T.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; Teng L.-J.; Liu C.-Y. |
| 臺大學術典藏 |
2020-12-18T08:38:51Z |
In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan
|
Chen Y.-H.; Liu C.-Y.; Lu J.-J.; King C.-H.R.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-12-18T08:38:50Z |
In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006
|
Liu C.-Y.; Lu C.-L.; Huang Y.-T.; Liao C.-H.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-12-18T08:38:48Z |
Cost minimisation analysis of antimicrobial treatment for intra-abdominal infections: a multicentre retrospective study from Taiwan
|
Po-Ren Hsueh;Liu C.-Y.;Shi Z.-Y.;Lee M.-H.;Chang F.-Y.;Yang M.-C.; PO-REN HSUEH; Liu C.-Y.; Shi Z.-Y.; Lee M.-H.; Chang F.-Y.; Yang M.-C. |
| 臺大學術典藏 |
2020-12-18T08:38:44Z |
Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole
|
PO-REN HSUEH; Wang H.-P.; Huang Y.-T.; Liao C.-H.; Liu C.-Y.; Lu C.-L.; Lu C.-L.;Liu C.-Y.;Liao C.-H.;Huang Y.-T.;Wang H.-P.;Po-Ren Hsueh |
| 臺大學術典藏 |
2020-12-18T08:38:43Z |
Prevalence and accessory gene regulator (agr) analysis of vancomycin-intermediate Staphylococcus aureus among methicillin-resistant isolates in Taiwan-SMART program, 2003
|
Ho C.-M.;Po-Ren Hsueh;Liu C.-Y.;Lee S.-Y.;Chiueh T.-S.;Shyr J.-M.;Tsao S.-M.;Chuang Y.-C.;Yan J.-J.;Wang L.-S.;Wang J.-H.;Ho M.-W.;Tien N.;Lu J.-J.; Ho C.-M.; PO-REN HSUEH; Liu C.-Y.; Lee S.-Y.; Chiueh T.-S.; Shyr J.-M.; Tsao S.-M.; Chuang Y.-C.; Yan J.-J.; Wang L.-S.; Wang J.-H.; Ho M.-W.; Tien N.; Lu J.-J. |
| 臺大學術典藏 |
2020-12-18T08:38:25Z |
Consensus statement on the role of fluoroquinolones in the management of urinary tract infections
|
Po-Ren Hsueh;Lau Y.-J.;Ko W.-C.;Liu C.-Y.;Huang C.-T.;Yen M.-Y.;Liu Y.-C.;Lee W.-S.;Liao C.-H.;Peng M.-Y.;Chen C.-M.;Chen Y.-S.; PO-REN HSUEH; Lau Y.-J.; Ko W.-C.; Liu C.-Y.; Huang C.-T.; Yen M.-Y.; Liu Y.-C.; Lee W.-S.; Liao C.-H.; Peng M.-Y.; Chen C.-M.; Chen Y.-S. |
| 臺大學術典藏 |
2020-12-18T08:38:15Z |
Clinical characteristics of infections caused by Tsukamurella spp. and antimicrobial susceptibilities of the isolates
|
PO-REN HSUEH; Liao C.-H.; Liu C.-Y.;Lai C.-C.;Lee M.-R.;Lee Y.-C.;Huang Y.-T.;Liao C.-H.;Po-Ren Hsueh; Liu C.-Y.; Lai C.-C.; Lee M.-R.; Lee Y.-C.; Huang Y.-T. |
| 臺大學術典藏 |
2020-12-18T08:38:14Z |
Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus
|
PO-REN HSUEH; Liu C.-L.; Wang J.-L.; Tang H.-J.; Hsieh P.-H.; Chiu F.-Y.; Chen Y.-H.; Chang M.-C.; Huang C.-T.; Liu C.-P.; Lau Y.-J.; Hwang K.-P.; Ko W.-C.; Wang C.-T.; Liu C.-Y. |
| 臺大學術典藏 |
2020-12-18T08:38:12Z |
Role of moxifloxacin for the treatment of commmunity-acquired complicated intra-abdominal infections in Taiwan
|
PO-REN HSUEH; Ko W.-C.; Chen C.-W.; Lee Y.-J.; Liu H.-D.; Liu J.-W.; Liu C.-Y.; Lee W.-S.; Huang C.-T.; Chen Y.-H.; Lau Y.-J. |
| 臺大學術典藏 |
2020-12-18T08:38:01Z |
Performance assessment of the DR. TBDR/NTM IVD kit for direct detection of Mycobacterium tuberculosis isolates, including rifampin-resistant isolates, and nontuberculous mycobacteria
|
PO-REN HSUEH; Lee M.-R.; Cheng A.; Huang Y.-T.; Liu C.-Y.; Chung K.-P.; Wang H.-C.; Liang S.-K.; Liao C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-12-18T08:38:01Z |
Streptococcus suis infection in Taiwan, 2000-2011
|
PO-REN HSUEH; Tsai H.-Y.; Liao C.-H.; Liu C.-Y.; Huang Y.-T.; Teng L.-J. |
| 臺大學術典藏 |
2020-12-18T08:37:57Z |
Emergence of tigecycline-resistant Klebsiella pneumoniae after tigecycline therapy for complicated urinary tract infection caused by carbapenem-resistant Escherichia coli
|
Liao C.-H.; Tsai H.-Y.; Cheng A.; Liu C.-Y.; Huang Y.-T.; Sheng W.-H.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-12-18T08:37:53Z |
Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: Results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009
|
Jean S.-S.;Po-Ren Hsueh;Lee W.-S.;Yu K.-W.;Liao C.-H.;Chang F.-Y.;Ko W.-C.;Wu J.-J.;Chen Y.-H.;Chen Y.-S.;Liu J.-W.;Lu M.-C.;Liu C.-Y.;Lam C.;Chen R.-J.; Jean S.-S.; PO-REN HSUEH; Lee W.-S.; Yu K.-W.; Liao C.-H.; Chang F.-Y.; Ko W.-C.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Liu C.-Y.; Lam C.; Chen R.-J. |
| 臺大學術典藏 |
2020-12-18T08:37:52Z |
Bacteremia caused by Pantoea agglomerans at a medical center in Taiwan, 2000-2010
|
Cheng A.;Liu C.-Y.;Tsai H.-Y.;Hsu M.-S.;Yang C.-J.;Huang Y.-T.;Liao C.-H.;Po-Ren Hsueh; Cheng A.; Liu C.-Y.; Tsai H.-Y.; Hsu M.-S.; Yang C.-J.; Huang Y.-T.; Liao C.-H.; PO-REN HSUEH |
